Pharmacogenomics tests are used to inform various factor about dosing and predict efficacy and adverse events for therapeutic agents. Most tests involve genetic testing, and in the case of cancer, both the DNA of the host and the tumor can be used to inform treatment choices. Pharmacoproteomic test are helpful in discovery of new biomarkers, which can help in the prediction of the ant disease as well as to monitor therapeutic progress. In our department I have established a Pharmacogenomics & Pharmacoproteomic laboratory to understand the disease like epilepsy, Alzheimer's, autism etc. in better way. We have a full flagged lab with the most advanced instrument like PCR, Spectrophotometer, Cold centrifuge, Sonicator, Elisa reader, deep freezer etc. As we monitor ADR in pharmacovigilance Centre, it is very necessary to evaluate all the adverse reaction on the genomic and proteomic level, so these facilities may play an important role to understand effect of the drug on the genome.